CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Nanoviricides, Inc.  (NNVC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
   Industry Medical Laboratories
   Sector  Healthcare

Nanoviricides's Quick Ratio

NNVC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth



Select the Comparisons : Select the Ratio:                        

NNVC Quick Ratio (Mar 31 2018)
III. Quarter
(Dec 31 2017)
II. Quarter
(Sep 30 2017)
I. Quarter
(Jun 30 2017)
IV. Quarter
(Mar 31 2017)
III. Quarter
Y / Y Current Liabilities Change 863.09 % -75.04 % -23.85 % -30.82 % -94.99 %
Y / Y Cash & cash equivalent Change -34.27 % -37.58 % -38.33 % -37.5 % -36.89 %
Quick Ratio MRQ 3.33 7.64 2.56 3.24 48.73
Overall Ranking # # # # #
Seq. Current Liabilities Change 102.59 % -70.17 % 13.25 % 1306.97 % -94.75 %
Seq. Cash & cash equivalent Change -11.86 % -10.85 % -10.51 % -6.53 % -16.3 %



Quick Ratio third quarter 2018 Comment
Due to increase in Current Liabilities in the third quarter 2018, Quick Ratio fell to 3.33 below Nanoviricides, Inc. average.

Within Medical Laboratories industry 13 other companies have achieved higher Quick Ratio than Nanoviricides in third quarter 2018. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are NNVC Segments?
See Quick Ratio NNVC on the trailing twelve month basis
Quick Ratio third quarter 2018 Company Ranking
Within: No.
Medical Laboratories Industry # 14
Healthcare Sector # 302
Overall Market # 732


Quick Ratio Statistics
High Average Low
64.81 18.77 2.56
(Mar 31 2015)   (Sep 30 2017)


You need to upgrade your Flash Player


Financial Statements
Nanoviricides's Current Liabilities $ 3 Millions Visit NNVC's Balance sheet
Nanoviricides's Cash & cash equivalent $ 11 Millions Visit NNVC's Balance sheet
Source of NNVC's Sales Visit NNVC's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2018, within Medical Laboratories Industry Quick RatioMar 31 2018 MRQ Cash & cash equivalentMar 31 2018 MRQ Current Liabilities
Yield10 Bioscience, Inc.  8.08 $ 11.574  Millions$ 1.432  Millions
Exelixis, Inc.  5.04 $ 427.424  Millions$ 84.859  Millions
Senomyx Inc  4.73 $ 18.074  Millions$ 3.824  Millions
China Health Industries Holdings, Inc.  4.33 $ 34.408  Millions$ 7.938  Millions
Cleveland Biolabs Inc  3.56 $ 7.684  Millions$ 2.156  Millions
Luna Innovations Inc  3.38 $ 33.443  Millions$ 9.889  Millions
Genomic Health Inc  3.37 $ 130.387  Millions$ 38.648  Millions
Enzo Biochem Inc  3.35 $ 62.556  Millions$ 18.668  Millions
Nanoviricides, Inc.  3.33 $ 10.621  Millions$ 3.194  Millions
Incyte Corp  3.07 $ 1,171.059  Millions$ 381.072  Millions
Pieris Pharmaceuticals, Inc.  2.91 $ 159.582  Millions$ 54.763  Millions
First Choice Healthcare Solutions, Inc.  2.33 $ 8.474  Millions$ 3.642  Millions
Veracyte, Inc.  2.29 $ 27.152  Millions$ 11.839  Millions
Opgen Inc  2.17 $ 10.292  Millions$ 4.744  Millions
Biocept Inc  1.90 $ 9.272  Millions$ 4.883  Millions
Psychemedics Corp  1.60 $ 8.284  Millions$ 5.172  Millions
Invitae Corp  1.56 $ 54.969  Millions$ 35.245  Millions
Intrexon Corp  1.42 $ 123.503  Millions$ 86.854  Millions
Caredx, Inc.  1.39 $ 18.695  Millions$ 13.445  Millions
Natera, Inc.  1.17 $ 119.371  Millions$ 101.632  Millions
Foundation Medicine, Inc.  1.04 $ 60.293  Millions$ 57.762  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NDSN's Profile

Stock Price

NDSN's Financials

Business Description

Fundamentals

Charts & Quotes

NDSN's News

Suppliers

NDSN's Competitors

Customers & Markets

Economic Indicators

NDSN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071